Stocksigma LogoStocksigma Logo

Ennature Bio Pharma Limited - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 7,846 (+44.9% YoY | -13.2% QoQ) ■ EBITDA: 1,034 (+71.2% YoY | +3.5% QoQ) ■ EBITDA Margin (%): 13.2 (+202 bps YoY | +213 bps QoQ) ■ PAT: 489

Ennature Bio Pharma Limited - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Ennature Bio Pharma Limited · Financial Result · 12 Nov 2026, 7:10 pm

Ennature Bio Pharma Limited - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 7,846 (+44.9% YoY | -13.2% QoQ) ■ EBITDA: 1,034 (+71.2% YoY | +3.5% QoQ) ■ EBITDA Margin (%): 13.2 (+202 bps YoY | +213 bps QoQ) ■ PAT: 489 (Loss to Profit YoY | +4.9% QoQ) ■ EPS (INR): 2.19 (Loss to Profit YoY | +4.8% QoQ)

Original exchange filing (PDF)

More announcements from Ennature Bio Pharma Limited

All Ennature Bio Pharma Limited announcements